1. Introduction {#sec1-viruses-12-00297}
===============

Among the retroviruses, HIV-1 is the most genetically diverse \[[@B1-viruses-12-00297],[@B2-viruses-12-00297],[@B3-viruses-12-00297],[@B4-viruses-12-00297]\], due to its higher mutation rate (reviewed by \[[@B5-viruses-12-00297],[@B6-viruses-12-00297]\]), genetic recombination, and fast viral replication \[[@B7-viruses-12-00297],[@B8-viruses-12-00297],[@B9-viruses-12-00297]\], where multiple unique sequences can be isolated from within single patients \[[@B10-viruses-12-00297],[@B11-viruses-12-00297],[@B12-viruses-12-00297],[@B13-viruses-12-00297],[@B14-viruses-12-00297]\]. This diversity allows for the emergence of resistance strains, and evasion from the host immune system and drug therapies. Under selection pressures (such as antiretroviral drugs), these drug-resistant mutations accumulate and become dominant strains \[[@B7-viruses-12-00297],[@B15-viruses-12-00297]\], rendering treatment regimens ineffective and hindering the development of effective vaccines \[[@B16-viruses-12-00297]\]. Thus, to combat viral diseases, HIV is an ideal model for studying drug resistance and emerging infections.

The genetic recombination of two single drug resistant strains can give rise to HIV-1 virions with multiple drug resistance \[[@B17-viruses-12-00297],[@B18-viruses-12-00297],[@B19-viruses-12-00297],[@B20-viruses-12-00297]\]. Coupled with high mutation rates, the estimated production of 10^9^ virions per day within an infected individual results in numerous mutant variants in a few viral generations \[[@B21-viruses-12-00297]\], with drug-resistant strains completely replaced by wild type strains within 2--4 weeks after antiretroviral treatment \[[@B7-viruses-12-00297]\].

The error rates and mutation frequencies of HIV-1 reverse transcriptase (RT) are reported to be approximately 10^−5^--10^−3^ errors/bp/cycle and 10^−4^--10^−2^ mutants/clones, respectively. However, the lack of consensus in mutation rates observed in HIV-1 suggests that multiple factors and contributors are involved (see [Table 1](#viruses-12-00297-t001){ref-type="table"} and Table 3).

In this review, we discuss the various experimental fidelity assays, their reported mutation rates, and the potential of non-active site allosteric mutations.

2. HIV-1 Reverse Transcriptase (RT) {#sec2-viruses-12-00297}
===================================

HIV-1 RT is an asymmetric heterodimer consisting of the p66 (66 kDa) and the p51 (51 kDa) subunits \[[@B22-viruses-12-00297]\] illustrated in [Figure 1](#viruses-12-00297-f001){ref-type="fig"}. It lacks the 3′ exonuclease proofreading activity \[[@B23-viruses-12-00297]\], contributing up to 68% mutations in cell-based assays during early stage replication (minus-strand synthesis and RNA transcription) and 32% during late stage replication (plus-strand synthesis and DNA repair) \[[@B24-viruses-12-00297]\]. HIV-1 RT has been found to contribute to HIV-1 mutagenesis \[[@B25-viruses-12-00297]\], accounting for 59.7% of the mutations in the viral RNA and 2.0% in the viral DNA \[[@B26-viruses-12-00297]\].

3. Comparison of Cell-Free and Cell-Based Fidelity Assays {#sec3-viruses-12-00297}
=========================================================

The fidelity of HIV-1 RT is best assessed directly on patient samples, but ethical and biosafety requirements are insurmountable obstacles for many small labs/institutes. Even without such obstacles, the virus would have undergone multiple generations of replication within a patient between sampling, making it nearly impossible to determine the fidelity of a single round of replication. Thus, various cell-free and cell-based approaches were developed.

3.1. Cell-Free Fidelity Assays {#sec3dot1-viruses-12-00297}
------------------------------

In vitro assays, termed "cell-free" assays to emphasize the absence of HIV replication in cells, reduce confounding factors (e.g., a balanced dNTP pool) to give higher reproducibility. However, such reductionist methods also remove factors that influence the fidelity of HIV RT, while employing high temperatures in PCR that could disrupt secondary structures of the template nucleic acid.

The first cell-free fidelity assays utilized synthetic polynucleotide templates to determine errors using a mismatched radio-labelled nucleotide \[[@B29-viruses-12-00297]\]. However, these homopolymer templates do not accurately represent the natural heteropolymer template (such as a gene), resulting in the overestimation of mutation rates due to their repeating nature \[[@B30-viruses-12-00297]\]. Confounding factors such as the slippage of primers and stacking interactions between nucleotides further influence the fidelity of base substitution \[[@B29-viruses-12-00297]\].

For the visual identification of mutants and non-mutants, reporter genes such as the α-complementing region of the lacZ gene (lacZα) and the DNA of bacteriophage ΦX174 are commonly employed in base reversion assays that measure the error rate of RT on a single base \[[@B30-viruses-12-00297]\]. However, RNA secondary structure influences are not considered, overlooking the spectrum of mutations and any potential mutational hotspots. To address this limitation, the cell-free forward mutation assay \[[@B31-viruses-12-00297]\] involving gap filling by RT, allows the determination of mutation spectra and hotspots. The error rates and mutant frequencies of HIV-1 RT from previously reported cell-free fidelity assays are shown in [Table 1](#viruses-12-00297-t001){ref-type="table"} and [Table 2](#viruses-12-00297-t002){ref-type="table"}, respectively.

3.2. Cell-Based Fidelity Assays {#sec3dot2-viruses-12-00297}
-------------------------------

In vivo assays, termed "cell-based" assays here, attempt to mimic the conditions to include host and viral proteins absent in cell-free assays. However, this trades off reproducibility when different cells are utilized. The assays leverage on transfecting shuttle vectors containing HIV genes into mammalian cells, followed by the selection of mutants in suitable hosts (e.g., bacteria). However, silent mutations are not detected, possibly leading to an overestimated fidelity of HIV RT in both cell-based and cell-free assays. The error rates and mutant frequencies of HIV-1 RT from previously reported cell-based fidelity assays are shown in [Table 3](#viruses-12-00297-t003){ref-type="table"} and [Table 4](#viruses-12-00297-t004){ref-type="table"}, respectively.

4. Studies on HIV-1 Genes {#sec4-viruses-12-00297}
=========================

For a better study of HIV-1 RT, the mutation positions are important to provide mechanistic insights to the development of drug resistance \[[@B76-viruses-12-00297]\]. The well-established mutation rate of HIV-1 RT is performed on lacZα \[[@B39-viruses-12-00297],[@B40-viruses-12-00297],[@B41-viruses-12-00297],[@B42-viruses-12-00297],[@B43-viruses-12-00297],[@B44-viruses-12-00297],[@B45-viruses-12-00297],[@B48-viruses-12-00297],[@B58-viruses-12-00297],[@B77-viruses-12-00297]\], resulting in a gap of knowledge regarding how HIV-1 genes are mutated by RT.

We found only two studies that utilized HIV templates \[[@B36-viruses-12-00297],[@B74-viruses-12-00297]\]. One involved the HIV-1 *env* gene (see [Table 5](#viruses-12-00297-t005){ref-type="table"}) in cell-free assays, finding an error rate in the DNA of 1.90 × 10^−4^ errors/bp/cycle, in RNA at 2.00 × 10^−4^ errors/bp/cycle and RNA/DNA at 3.80 × 10^−4^ errors/bp/cycle. This is comparable to previous M13mp2 forward assays using the lacZα template in DNA at 1.69 × 10^−4^ and RNA at 1.45 × 10^−4^ error/bp/cycle \[[@B36-viruses-12-00297]\]. Similarly, Geller and colleagues' work on HIV *env* and *int-vir-vpr* RNA, found error rates of 0.36 × 10^−4^ and 0.75 × 10^−4^ error/bp/cycle, respectively \[[@B74-viruses-12-00297]\].

Mutations reported in the first study were found to partially correlate with those found in AIDS patients \[[@B36-viruses-12-00297]\], while the latter showed that sequence and secondary structure affected the activity of cytidine deamination and fidelity of HIV RT \[[@B74-viruses-12-00297]\]. Together, they demonstrate the need to perform studies directly on HIV-1 genes.

5. Analysis of Allosteric Communication {#sec5-viruses-12-00297}
=======================================

Current anti-HIV drugs target the key viral enzymes such as reverse transcriptase, integrase, and protease \[[@B78-viruses-12-00297]\], and, as such, occurrences of mutations hotspots within these targets are essential for understanding drug resistance and the design of new drugs.

Clinical mutations were found not only at the direct drug-binding sites but also non-functional regions \[[@B79-viruses-12-00297]\], the latter of which can have indirect effects on drug resistance such as allosteric communication to the catalytic sites. The inhibition of such communication can be explored for novel classes of drugs, such as in the case of reverse transcriptase inhibitors (RTIs) \[[@B80-viruses-12-00297]\], integrase inhibitors \[[@B81-viruses-12-00297]\], and protease inhibitors (PIs) \[[@B82-viruses-12-00297]\]. The non-nucleoside RTIs bind non-competitively to an allosteric site on p66 subunit to cause structural changes in the RT polymerase active site, hindering DNA polymerization. Our ongoing study has found further potential interferences targeting the p51 to affect overall RT activity \[[@B83-viruses-12-00297]\]. On integrase, allosteric inhibitors impair the binding of integrase and the cellular cofactor LEDGF/p75 during HIV-1 replication to induce aberrant integrase multimerization \[[@B81-viruses-12-00297]\]. Similarly, a potential allosteric protease inhibitor was found to bind to a site at the protease flap to equipotently inhibit both wild-type and certain drug-resistant variants \[[@B82-viruses-12-00297]\].

Given the resource constraints for experimentally testing every residue for allosteric communication, *in silico* screening can be performed on potential mutation hotspots. Following experimental validation via recombinant methods to establish the level and type of effect (detrimental or augmented catalytic activity), the site can then be targeted for intervention, especially if they are able to elicit drastic protein structural changes to affect functionality. One such example is in IgA1 and IgA2, which had varying allosteric communications due to different intermediate protein regions \[[@B84-viruses-12-00297]\].

Recent advances have shown the p51 subunit of HIV-1 RT to induce flexibility on the DNA polymerase active site on p66, inhibiting RT function \[[@B85-viruses-12-00297]\]. Similarly, Gag non-cleavage site mutations that are known to compensate for viral fitness in drug resistance were found to have allosteric communications \[[@B86-viruses-12-00297]\] with the first protease cleavage site on Gag \[[@B87-viruses-12-00297]\]. While further research is on-going, the example of non-cleavage Gag mutations involved in protease inhibitor resistance (despite an absence of mutations in the cleavage sites) demonstrates the importance of non-active site mutations that exhibit allosteric communications \[[@B75-viruses-12-00297],[@B88-viruses-12-00297]\].

For this review, the locations in the various HIV target proteins were screened for their allosteric communication to the known active sites. To quantify the strength of allosteric effects caused by each residual mutation, allosteric-free energy (ΔΔg~residue~) was calculated (using AlloSigMA, more details in \[[@B89-viruses-12-00297],[@B90-viruses-12-00297],[@B91-viruses-12-00297]\]) for the other responding residues. Individual perturbations for the whole protein are shown in the allosteric signaling map \[[@B92-viruses-12-00297],[@B93-viruses-12-00297]\] of [Figure 2](#viruses-12-00297-f002){ref-type="fig"}.

Asymmetrical effects in the HIV-1 RT structure further affirmed that mutations in p51 could stabilize the active site on p66, but not vice versa ([Figure 2](#viruses-12-00297-f002){ref-type="fig"}A). Since rigidity reduces HIV-1 RT activity \[[@B94-viruses-12-00297]\], this opens up p51 as a potential new drug target. Given the estimated allosteric-free energies at the DNA polymerase active site (ΔΔg~site~ by averaging all ΔΔg~residue~ of the residues involving in the active site to demonstrate stabilizing (ΔΔg~site~ \< 0) or destabilizing (ΔΔg~site~ \> 0) effects), it showed that the active site is destabilized by mutations on the thumb domain of p66 (residues 260-321) and on p51 (residues 33--42, 68--78, and 96--114), highlighted in red spheres and red dash ovals in [Figure 2](#viruses-12-00297-f002){ref-type="fig"}B. These sites can thus be targeted for intervention.

Differing from RT, symmetrical allosteric communications between domains in HIV-1 integrase and protease are found \[[@B95-viruses-12-00297],[@B96-viruses-12-00297]\], probably resulting from the homo-multimerization ([Figure 2](#viruses-12-00297-f002){ref-type="fig"}A). Mutations on the C-terminal domain (CTD, residues 220--221, 230--232, and 211--217) of integrase and at the "ears" regions of protease (residues 33--45 and 57--63, of which residues L33, E34, and M36 were reported to be resistant to several protease inhibitors \[[@B79-viruses-12-00297]\]) have been found to affect the active sites of the two enzymes ([Figure 2](#viruses-12-00297-f002){ref-type="fig"}B). For the Gag protein, allosteric communications between several non-cleavage sites and the cleavage sites were found, affecting proteolysis \[[@B87-viruses-12-00297]\], e.g., on Gag matrix (MA: residues E12, V35, E40, and L75), capsid (CA: residue H219), and p6 (L449 and P453) domains \[[@B88-viruses-12-00297],[@B97-viruses-12-00297],[@B98-viruses-12-00297]\]. By analyzing mutational hotspots, additional sites with allosteric communications can be identified for pre-emptive drug design.

6. Implications on Sagacious Drug Design {#sec6-viruses-12-00297}
========================================

The control of viral mutation rates has been proposed as an antiretroviral strategy \[[@B6-viruses-12-00297]\]. In this review, we further propose identifying mutational hotspots and mutation rates of specific viral drug targets towards an application of rational drug design, that can include the development and pre-emptive design of novel drugs. While generic HIV-1 RT mutation rates are well-established from multiple studies reviewed in this article, there are still gaps when looking at specific HIV genes, especially given that sequence context and secondary structure are known to influence the fidelity of HIV-1 RT \[[@B74-viruses-12-00297]\]. Within these targets, an in-depth understanding of the mutation rate and types of mutation (e.g., substitution, deletion and insertion) and predisposition to specific nucleotide changes (e.g., A to G) can shed light on viral drug resistance. Such knowledge allows for the targeting of regions with lower mutation rates while balancing possible allosteric effects or compensatory effects of viral fitness in a sagacious drug design strategy. For example, the M184V resistance mutation in HIV-1 RT is known to increase fidelity, impair viral fitness, and increase hyper-sensitization to NRTIs (such as amprenavir and efavirenz) \[[@B99-viruses-12-00297]\]. Thus, it is possible to leverage on such features alongside structural understanding \[[@B76-viruses-12-00297]\] to utilize combinatorial therapies to target the active site, using existing inhibitors to select for the mutation alongside other inhibitors to limit the escape mutations.

7. Conclusions and Future Perspective {#sec7-viruses-12-00297}
=====================================

Comparing cell-free and cell-based essays that contribute to the mutation rate of HIV-1, there is a lack of study of specific HIV-1 drug targets that would provide insights for rational drug designs, especially in the light of in silico allosteric analysis. Addressing such gaps has great promise for gaining an upper hand to develop novel intervention strategies against HIV.
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![Human immunodeficiency virus type 1 (HIV-1) Reverse Transcriptase structure complexed with DNA (pdb 1T05) \[[@B27-viruses-12-00297]\]. The image was generated using PyMOL \[[@B28-viruses-12-00297]\].](viruses-12-00297-g001){#viruses-12-00297-f001}

![Underlying allosteric communications were found within HIV-1 proteins. (**A**) Allosteric signaling maps (single-point mutation screening) of HIV-1 Reverse Transcriptase, Integrase, Protease, and Gag. Structural presentation using RT (pdb 3T19), IN (reconstructed from pdb 1K6Y and 1EX4), PR (pdb 2PC0), and Gag model from Su et al. \[[@B87-viruses-12-00297]\]; (**B**) Allosteric-free energies (ΔΔg~site~) on specific catalytic or cleavage sites (magenta spheres) were estimated based on individual perturbations at single residues (x-axis) to demonstrate the resulting stabilizing (ΔΔg~site~ \< 0) or destabilizing (ΔΔg~site~ \> 0) effects. The possible mutations which may potentially destabilize the sites of interest, are highlighted in red spheres and red dash ovals.](viruses-12-00297-g002){#viruses-12-00297-f002}

viruses-12-00297-t001_Table 1

###### 

Error rates of HIV-1 reverse transcriptase (RT) measured in cell-free fidelity assays.

  Assay                               RT Mutant            Vector                  Reporter Gene/Template                      Error Rate (× 10^−4^ errors/bp/cycle)   Reference
  ----------------------------------- -------------------- ----------------------- ------------------------------------------- --------------------------------------- -----------------------------------------------------
  Base reversion                      WT ^1^               ΦX174 am3               Position 587 of ΦX174 am3, DNA              2.50                                    \[[@B32-viruses-12-00297]\]
  Base reversion                      WT ^1^               M13mp2                  Position 89 of lacZα coding sequence, DNA   0.55                                    \[[@B23-viruses-12-00297]\]
  Forward mutation                    *lacZ*α, DNA         5.00--6.67                                                                                                  
  Misincorporation                    WT (HTLV-III~B~)     \-                      Polyadenylic acid                           0.31--0.57                              \[[@B33-viruses-12-00297]\]
  WT (HIV\[GUN-1\])                   \-                   0.26--0.38                                                                                                  
  Base reversion                      WT (HTLV-III)        ΦX174 am16              ΦX174 am16, DNA                             1.43--2.00                              \[[@B34-viruses-12-00297]\]
  Forward mutation                    WT ^1^               \-                      *lacZ*α, RNA                                1.45                                    \[[@B35-viruses-12-00297]\]
  \-                                  M13mp2 (+), DNA      1.69                                                                                                        
  Forward mutation                    WT ^1^               \-                      *env* V-1, DNA                              1.90                                    \[[@B36-viruses-12-00297]\]
  \-                                  *env* V-1, RNA       2.00                                                                                                        
  \-                                  *env* V-1, RNA/DNA   3.80                                                                                                        
  Forward mutation                    WT (BH10)            M13mp19 (CSIVM13B)      SIV~agm~TYO-7 *env* (minus-strand)*,* DNA   0.18                                    \[[@B37-viruses-12-00297]\]
  M13mp19 (CSIVM13B)                  *lacZ*α, DNA         0.53                                                                                                        
  Forward mutation                    WT (BH10)            M13mp2                  *lacZ*α, DNA                                0.45                                    \[[@B38-viruses-12-00297]\]
  Q151M (BH10)                        0.40                                                                                                                             
  A62V/V75I/F77L/F116Y/Q151M (BH10)   0.23                                                                                                                             
  Forward mutation                    WT (HXB2)            M13mp2                  *lacZ*α, DNA                                0.57                                    \[[@B39-viruses-12-00297]\]
  E89G (HXB2)                         0.41                                                                                                                             
  M184V (HXB2)                        0.36                                                                                                                             
  E89G/M184V (HXB2)                   0.81                                                                                                                             
  Forward mutation                    WT (HXB2)            M13mp2                  *lacZ*α, DNA                                0.71                                    \[[@B39-viruses-12-00297],[@B40-viruses-12-00297]\]
  M184V (HXB2)                        0.43                                                                                                                             
  Forward mutation                    M184I (HXB2)         M13mp2                  *lacZ*α, DNA                                0.17                                    \[[@B40-viruses-12-00297]\]
  Forward mutation                    WT ^1^               U-DNA Litmus 29 (Not)   *lacZ*α, DNA                                1.60                                    \[[@B41-viruses-12-00297]\]
  Y115F ^1^                           1.00                                                                                                                             
  Y115V ^1^                           4.70                                                                                                                             
  Forward mutation                    WT (HXB2)            M13mp2                  *lacZ*α, DNA                                0.57                                    \[[@B42-viruses-12-00297]\]
  K65R (HXB2)                         0.07                                                                                                                             
  L74V (HXB2)                         0.30                                                                                                                             
  Forward mutation                    WT (NL4-3)           M13mp2                  *lacZ*α, DNA                                0.63                                    \[[@B43-viruses-12-00297]\]
  FE20 (NL4-3)                        0.56                                                                                                                             
  FE103 (NL4-3)                       0.53                                                                                                                             
  Forward mutation                    WT ^1^               U-DNA Litmus 29 (Not)   *lacZ*α, DNA                                0.75                                    \[[@B44-viruses-12-00297]\]
  Forward mutation                    WT (BH10)            M13mp2                  *lacZ*α, DNA                                1.36                                    \[[@B45-viruses-12-00297]\]
  WT (ESP49)                          0.55                                                                                                                             
  V75I (ESP49)                        0.29                                                                                                                             
  Forward mutation                    D433N (ESP49)        M13mp2                  *lacZ*α, DNA                                0.14                                    \[[@B46-viruses-12-00297]\]
  E478Q (ESP49)                       0.1                                                                                                                              
  V75I/D443N (ESP49)                  0.14                                                                                                                             
  V75I/E478Q (ESP49)                  0.2                                                                                                                              
  E478Q (BH10)                        0.42                                                                                                                             
  Forward mutation                    WT (BH10)            M13mp2                  *lacZ*α, DNA                                1.52                                    \[[@B47-viruses-12-00297]\]
  WT (ROD)                            1.00                                                                                                                             
  K65R (ROD)                          0.84                                                                                                                             
  K65R/Q151M/M184V (ROD)              0.74                                                                                                                             
  Forward mutation                    WT (BH10)            M13mp2                  *lacZ*α, RNA                                0.35                                    \[[@B48-viruses-12-00297]\]
  WT (ESP49)                          0.27                                                                                                                             
  K65R (ESP49)                        0.26                                                                                                                             
  K65R/V75I (ESP49)                   0.25                                                                                                                             

^1^ Lab strain of HIV-1 RT used was not mentioned.

viruses-12-00297-t002_Table 2

###### 

Mutant frequencies of HIV-1 RT measured in cell-free fidelity assays.

  Assay                                   RT Mutant         Vector                                      Reporter Gene/Template                        Mutant Frequency (× 10^−4^ Mutants/Clones)   Reference
  --------------------------------------- ----------------- ------------------------------------------- --------------------------------------------- -------------------------------------------- -----------------------------------------------------
  Base reversion                          WT ^1^            M13mp2                                      Position 89 of *lacZ*α coding sequence, DNA   1.00                                         \[[@B23-viruses-12-00297]\]
  Forward mutation                        WT ^1^            M13mp2                                      *lacZ*α, DNA                                  340--460                                     
  Forward mutation                        WT ^1^            M13mp2                                      *lacZ*α, DNA                                  390.00                                       \[[@B49-viruses-12-00297]\]
  Base reversion                          WT ^1^            pTZ18R                                      ΦX174 am16, RNA                               26.00                                        \[[@B50-viruses-12-00297]\]
  ΦX174 am16, DNA                         26.00                                                                                                                                                    
  Forward mutation                        WT ^1^            M13mp2                                      *lacZ*α, DNA                                  340--540                                     \[[@B51-viruses-12-00297]\]
  *lacZ*α, RNA                            91--210                                                                                                                                                  
  Forward mutation                        WT ^1^            M13mp2                                      *lacZ*α, RNA                                  40.70                                        \[[@B35-viruses-12-00297]\]
  pBluescript SK+                         M13mp2, (+) DNA   47.30                                                                                                                                  
  Forward mutation                        WT ^1^            M13mp2                                      pseudowild type 1 (pwt1) *lacZα*, DNA         490                                          \[[@B52-viruses-12-00297]\]
  pseudowild type 2 (pwt2) *lacZα*, DNA   450                                                                                                                                                      
  *lacZ*α, DNA                            500                                                                                                                                                      
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  200                                          \[[@B53-viruses-12-00297]\]
  D256A (HXB2)                            240                                                                                                                                                      
  Q258A (HXB2)                            390                                                                                                                                                      
  K259A (HXB2)                            300                                                                                                                                                      
  L260A (HXB2)                            230                                                                                                                                                      
  G262A (HXB2)                            880                                                                                                                                                      
  K263A (HXB2)                            290                                                                                                                                                      
  W266A (HXB2)                            640                                                                                                                                                      
  Q269A (HXB2)                            510                                                                                                                                                      
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  210                                          \[[@B54-viruses-12-00297]\]
  G262A (HXB2)                            860                                                                                                                                                      
  W266A (HXB2)                            630                                                                                                                                                      
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  160                                          \[[@B55-viruses-12-00297]\]
  R277A (HXB2)                            140                                                                                                                                                      
  Q278A (HXB2)                            190                                                                                                                                                      
  L279A (HXB2)                            150                                                                                                                                                      
  C280A (HXB2)                            300                                                                                                                                                      
  K281A (HXB2)                            140                                                                                                                                                      
  L282A (HXB2)                            120                                                                                                                                                      
  R284A (HXB2)                            170                                                                                                                                                      
  G285A (HXB2)                            160                                                                                                                                                      
  K287A (HXB2)                            120                                                                                                                                                      
  Forward mutation                        WT (BH10)         M13mp19 (CSIVM13B)                          SIV~agm~TYO-7 *env* (minus-strand)*,* DNA     31.40                                        \[[@B37-viruses-12-00297]\]
  *lacZ*α, DNA                            60.90                                                                                                                                                    
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  232                                          \[[@B56-viruses-12-00297]\]
  D76V (BH10)                             26                                                                                                                                                       
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  64.00                                        \[[@B38-viruses-12-00297]\]
  Q151M (BH10)                            55.00                                                                                                                                                    
  A62V/V75I/F77L/F116Y/Q151M (BH10)       31.00                                                                                                                                                    
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  86.00                                        \[[@B39-viruses-12-00297]\]
  E89G (HXB2)                             62.60                                                                                                                                                    
  M184V (HXB2)                            55.30                                                                                                                                                    
  E89G/M184V (HXB2)                       123.00                                                                                                                                                   
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  97                                           \[[@B39-viruses-12-00297],[@B40-viruses-12-00297]\]
  M184V (HXB2)                            59                                                                                                                                                       
  Forward mutation                        M184I (HXB2)      M13mp2                                      *lacZ*α, DNA                                  24                                           \[[@B40-viruses-12-00297]\]
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  250                                          \[[@B57-viruses-12-00297]\]
  R78A (BH10)                             28                                                                                                                                                       
  Base reversion                          WT (HXB2)         TGA codon (position 87--89) in lacZα, DNA   2.2                                           \[[@B58-viruses-12-00297]\]                  
  R72A (HXB2)                             82                                                                                                                                                       
  One-nucleotide deletion reversion       WT (HXB2)         TTTT run in M13mp2 DNA                      32                                                                                         
  R72A (HXB2)                             1.6                                                                                                                                                      
  Forward mutation                        WT (HXB2)         *lacZ*α, DNA                                210                                                                                        
  R72A (HXB2)                             340                                                                                                                                                      
  Forward mutation                        WT ^1^            U-DNA Litmus 29 (Not)                       *lacZ*α, DNA                                  278.00                                       \[[@B41-viruses-12-00297]\]
  Y115F ^1^                               175.00                                                                                                                                                   
  Y115V ^1^                               82.00                                                                                                                                                    
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  192                                          \[[@B59-viruses-12-00297]\]
  L74V (BH10)                             55                                                                                                                                                       
  E89G (BH10)                             96                                                                                                                                                       
  M184V (BH10)                            228                                                                                                                                                      
  Y183F (BH10)                            303                                                                                                                                                      
  Y115A (BH10)                            763                                                                                                                                                      
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  86                                           \[[@B42-viruses-12-00297]\]
  K65R (HXB2)                             10.6                                                                                                                                                     
  L74V (HXB2)                             50.5                                                                                                                                                     
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  261                                          \[[@B60-viruses-12-00297]\]
  Q151N (BH10)                            20                                                                                                                                                       
  K154A (BH10)                            125                                                                                                                                                      
  Forward mutation                        WT (NL4-3)        M13mp2                                      *lacZ*α, DNA                                  86.00                                        \[[@B43-viruses-12-00297]\]
  FE20 (NL4-3)                            77.00                                                                                                                                                    
  FE103 (NL4-3)                           74.00                                                                                                                                                    
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  97                                           \[[@B61-viruses-12-00297]\]
  F61A (HXB2)                             8.3                                                                                                                                                      
  Forward mutation                        V184I (HXB2)      M13mp2                                      *lacZ*α, DNA                                  30                                           \[[@B62-viruses-12-00297]\]
  Forward mutation                        E89K (HXB2)       M13mp2                                      *lacZ*α, DNA                                  77                                           \[[@B63-viruses-12-00297]\]
  E89V (HXB2)                             64                                                                                                                                                       
  E89S (HXB2)                             53                                                                                                                                                       
  Forward mutation                        WT (HXB2)         M13mp2                                      *lacZ*α, DNA                                  97                                           \[[@B64-viruses-12-00297]\]
  T69S-AG (HXB2)                          20                                                                                                                                                       
  T69S-SG (HXB2)                          12                                                                                                                                                       
  T69S-SS (HXB2)                          24                                                                                                                                                       
  A62V/T69S-AG/L210W/R211K/L214F/T215Y    8.5                                                                                                                                                      
  A62V/T69S-SG/L210W/R211K/L214F/T215Y    19                                                                                                                                                       
  A62V/T69S-SS/L210W/R211K/L214F/T215Y    11                                                                                                                                                       
  M41L/T69S-AG/L210W/R211K/L214F/T215Y    6.3                                                                                                                                                      
  M41L/T69S-SG/L210W/R211K/L214F/T215Y    5.9                                                                                                                                                      
  Forward mutation                        WT ^1^            U-DNA Litmus 29 (Not)                       *lacZ*α, DNA                                  130.00                                       \[[@B44-viruses-12-00297]\]
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  206                                          \[[@B65-viruses-12-00297]\]
  V75A (BH10)                             281                                                                                                                                                      
  V75F (BH10)                             112                                                                                                                                                      
  V75I (BH10)                             69.6                                                                                                                                                     
  Base reversion                          WT (BH10)         27                                                                                                                                     
  V75I (BH10)                             7.8                                                                                                                                                      
  Forward mutation                        WT (ESP49)        M13mp2                                      *lacZ*α, DNA                                  83.1                                         \[[@B45-viruses-12-00297]\]
  V75I (ESP49)                            43.4                                                                                                                                                     
  Forward mutation                        K65R (ESP49)      M13mp2                                      *lacZ*α, DNA                                  7.7                                          \[[@B66-viruses-12-00297]\]
  K65R/V75I (ESP49)                       8.9                                                                                                                                                      
  R78A (ESP49)                            5.9                                                                                                                                                      
  Forward mutation                        WT (ESP49)        M13mp2                                      *lacZ*α, DNA                                  96                                           \[[@B46-viruses-12-00297]\]
  D433N (ESP49)                           19.8                                                                                                                                                     
  E478Q (ESP49)                           13.5                                                                                                                                                     
  V75I/D443N (ESP49)                      18.2                                                                                                                                                     
  V75I/E478Q (ESP49)                      29.1                                                                                                                                                     
  WT (BH10)                               113.4--132.3                                                                                                                                             
  E478Q (BH10)                            57.6                                                                                                                                                     
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  199.00                                       \[[@B47-viruses-12-00297]\]
  WT (ROD)                                124.20                                                                                                                                                   
  K65R (ROD)                              117.90                                                                                                                                                   
  K65R/Q151M/M184V (ROD)                  103.10                                                                                                                                                   
  Forward mutation                        WT (BH10)         M13mp2                                      *lacZ*α, DNA                                  40.50                                        \[[@B48-viruses-12-00297]\]
  WT (ESP49)                              34.5                                                                                                                                                     
  K65R (ESP49)                            29.5                                                                                                                                                     
  K65R/V75I (ESP49)                       29.3                                                                                                                                                     

^1^ The lab strain of HIV-1 RT used was not mentioned.

viruses-12-00297-t003_Table 3

###### 

Error rates of HIV-1 RT measured in cell-based fidelity assays.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Assay                                          RT Mutant                 Vector                                     Reporter Gene/Template    Error Rate\                  Reference
                                                                                                                                                (× 10^−4^ errors/bp/cycle)   
  ---------------------------------------------- ------------------------- ------------------------------------------ ------------------------- ---------------------------- -----------------------------
  Forward mutation                               WT (NL4-3)                HIV-1 vector (HIV shuttle 3.12 & 5.1)      *lacZ*α, DNA              0.34                         \[[@B67-viruses-12-00297]\]

  Forward mutation                               WT (NL4-3)                HIV-1 vector (HIV shuttle 3.12)            *lacZ*α, DNA              0.40                         \[[@B68-viruses-12-00297]\]

  Forward mutation                               WT (NL4-3)                HIV-1 vector (HIV shuttle 3.12 *vpr^+^)*   *lacZ*α, DNA              0.30                         \[[@B69-viruses-12-00297]\]

  HIV-1 vector (HIV shuttle 3.12 *vpr* ATG^−^)   1.20                                                                                                                        

  Forward mutation (SSCP)                        WT (HXB2)                 HIV-1 vector (pHIV-gpt)                    HIV-1 LTR, DNA            0.92                         \[[@B25-viruses-12-00297]\]

  WT (NL4-3)                                     HIV-1 vector (NL4-3gpt)   0.79                                                                                              

  Forward mutation                               WT (NL4-3)                HIV-1 vector (pNL4-3deltaΔ +cass)          *tk,* DNA                 0.22                         \[[@B70-viruses-12-00297]\]

  Forward mutation                               WT (NL4-3)                HIV-1 vector (pNL4-3 HIG)                  U373-MAGI-X4 cells, DNA   6.90                         \[[@B71-viruses-12-00297]\]

  Forward mutation                               WT (NL4-3)                HIV-1 vector (pSICO-LZF)                   *lacZ*α, DNA              0.22                         \[[@B72-viruses-12-00297]\]

  HIV-1 vector (pSICO-LZR)                       0.17                                                                                                                        

  Forward mutation                               WT (NL4-3)                HIV-1 vector (pSICO-LZF/R)                 *lacZ*α, DNA              0.14                         \[[@B73-viruses-12-00297]\]

  Y115F (NL4-3)                                  0.37                                                                                                                        

  Q151M (NL4-3)                                  0.17                                                                                                                        

  M184I (NL4-3)                                  0.21                                                                                                                        

  M184V (NL4-3)                                  0.18                                                                                                                        

  Forward mutation                               WT (HX2B2)                HIV-1 vector (pSDY-dCK)                    HIV *env*, RNA            0.36                         \[[@B74-viruses-12-00297]\]

  HIV *Int-vif-vpr*, RNA                         0.75                                                                                                                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

viruses-12-00297-t004_Table 4

###### 

Mutant frequencies of HIV-1 RT measured in cell-based fidelity assays.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Assay                                RT Mutant          Vector                            Reporter Gene/Template   Mutant Frequency\           Reference
                                                                                                                     (× 10^−4^ Mutants/Clones)   
  ------------------------------------ ------------------ --------------------------------- ------------------------ --------------------------- -----------------------------
  Forward mutation                     WT (NL4-3)         HIV-1 vector\                     *lacZ*α, DNA             44                          \[[@B67-viruses-12-00297]\]
                                                          (HIV shuttle 3.12)                                                                     

  HIV-1 vector\                        42                                                                                                        
  (HIV shuttle 5.2)                                                                                                                              

  Forward mutation                     WT (NL4-3)         HIV-1 vector\                     *lacZ*α, DNA             50                          \[[@B68-viruses-12-00297]\]
                                                          (HIV shuttle 3.12)                                                                     

  Forward mutation                     WT (NL4-3)         HIV-1 vector\                     *lacZ*α, DNA             150                         \[[@B69-viruses-12-00297]\]
                                                          (HIV shuttle 3.12 *vpr* ATG^−^)                                                        

  HIV-1 vector\                        140                                                                                                       
  (HIV shuttle 3.12 *vpr* A30F)                                                                                                                  

  HIV-1 vector\                        40                                                                                                        
  (HIV shuttle 3.12 *vpr^+^)*                                                                                                                    

  Forward mutation                     WT (NL4-3)         HIV-1 vector                      *lacZ*α, DNA             1500--1510 ^2^              \[[@B75-viruses-12-00297]\]

  K65R (NL4-3)                         450 ^2^                                                                                                   

  D67N (NL4-3)                         1490 ^2^                                                                                                  

  K70R (NL4-3)                         1470^2^                                                                                                   

  L74V (NL4-3)                         1120^2^                                                                                                   

  D76V (NL4-3)                         590--600 ^2^                                                                                              

  R78A (NL4-3)                         420--430 ^2^                                                                                              

  E89G (NL4-3)                         120^2^                                                                                                    

  Y115A (NL4-3)                        3400--3480 ^2^                                                                                            

  Q151N (NL4-3)                        250--280 ^2^                                                                                              

  K154A (NL4-3)                        1520 ^2^                                                                                                  

  F227A (NL4-3)                        930 ^2^                                                                                                   

  W229A (NL4-3)                        720 ^2^                                                                                                   

  Y501W (NL4-3)                        4300 ^2^                                                                                                  

  I505A (NL4-3)                        1410 ^2^                                                                                                  

  D76V/R78A (NL4-3)                    150 ^2^                                                                                                   

  R78A/Q151N (NL4-3)                   110 ^2^                                                                                                   

  Y115A/Q151N (NL4-3)                  1050 ^2^                                                                                                  

  Forward mutation                     WT (NL4-3)         HIV-1 vector\                     *lacZ*α, DNA             1490                        \[[@B62-viruses-12-00297]\]
                                                          (HIV shuttle 3.12)\                                                                    

  V148I (NL4-3)                        390                                                                                                       

  Q151N (NL4-3)                        260                                                                                                       

  Forward mutation                     WT (NL4-3)         HIV-1 vector\                     *lacZ*α (F), DNA         38                          \[[@B72-viruses-12-00297]\]
                                                          (pSICO-LZF/R)                                                                          

  HIV-1 vector\                        *lacZ*α (R), DNA   21.8                                                                                   
  (pSICO-LZF/R)                                                                                                                                  

  HIV-1 vector\                        *lacZ*α (F), DNA   21.7                                                                                   
  (pNLZeoIN-R-E-.LZF/R)                                                                                                                          

  HIV-1 vector (pNLZeoIN-R-E-.LZF/R)   *lacZ*α (R), DNA   18.2                                                                                   

  Forward mutation                     WT (NL4-3)         HIV-1 vector (pSICO-LZF/R)        *lacZ*α, DNA             21.98                       \[[@B73-viruses-12-00297]\]

  Y115F (NL4-3)                        55.91                                                                                                     

  Q151M (NL4-3)                        25.69                                                                                                     

  M184I (NL4-3)                        31.9                                                                                                      

  M184V (NL4-3)                        27                                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^2^ Mutant frequency was calculated as mutants/cycle.

viruses-12-00297-t005_Table 5

###### 

Percentages of nucleotide mutations of HIV-1 RT on the HIV-1 gene and LacZα template.

  Template                   Base Substitutions   Frameshifts   Others       Reference                                                                                                                                                                              
  -------------------------- -------------------- ------------- ------------ ------------ ---------- ----------- ----------------------------- ---------- ------------ ------------ ------------ ----------- ------------ ----------- ----------------------------- -----------------------------
  HIV-1 *env* V-1, DNA       0                    0             1.59 (1)     1.59 (1)     1.59 (1)   0           4.76 (3)                      6.35 (4)   9.52 (6)     26.98 (17)   15.87 (10)   4.76 (3)    23.81 (15)   3.17 (2)    0                             \[[@B36-viruses-12-00297]\]
  HIV-1 *env* V-1, DNA/RNA   7.55 (4)             0             3.77 (2)     3.77 (2)     0          0           16.98 (9)                     0          3.77 (2)     20.75 (11)   16.98 (9)    13.21 (7)   7.55 (4)     5.66 (3)    0                             
  HIV-1 *env*                27.88 (29)           46.15 (48)    15.38 (16)   8.65 (9)     1.92 (2)   0           \[[@B74-viruses-12-00297]\]                                                                                                                        
  HIV-1 *int-vif-vpr*        19.61 (20)           50.98 (52)    22.55 (23)   4.90 (2)     1.96 (2)   0                                                                                                                                                              
  *LacZα*, RNA               \-                   \-            \-           \-           \-         10.64 (5)   23.40 (11)                    \-         0            \-           31.91 (15)   2.13 (1)    14.89 (7)    17.02 (8)   \[[@B35-viruses-12-00297]\]   
  LacZα, DNA                 0                    31.53 (70)    0            30.63 (68)   0.45 (1)   0.45 (1)    0                             0.90 (2)   12.61 (28)   3.60 (8)     4.95 (11)    0           14.86 (33)   0           \[[@B41-viruses-12-00297]\]   
  LacZα, DNA                 0.57 (1)             11.93 (21)    0            9.66 (17)    0          2.27 (4)    0                             0.57 (1)   45.45 (80)   6.25 (11)    7.39 (13)    1.14 (2)    10.23 (18)   4.55 (8)    \[[@B44-viruses-12-00297]\]   

Reported percentages were calculated using previous research, with exact reported numbers indicated in parentheses.

[^1]: These authors contributed equally to this manuscript.
